Study of VIB7734 for the Treatment of Moderate to Severely Active SLE
Public ClinicalTrials.gov record NCT04925934. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of VIB7734 for the Treatment of Moderate to Severely Active Systemic Lupus Erythematosus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of VIB7734 for the Treatment of Moderate to Severely Active Systemic Lupus Erythematosus in approximately 195 participants. The study duration will be 48 weeks, with a safety follow-up through week 56.There will be 3 parallel arms - 2 active treatment and 1 placebo.
Study identification
- NCT ID
- NCT04925934
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 214 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 27, 2021
- Primary completion
- May 15, 2023
- Completion
- Jun 8, 2023
- Last update posted
- Jul 22, 2024
2021 – 2023
United States locations
- U.S. sites
- 17
- U.S. states
- 9
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Inland Rheumatology Clinical Trials Incorporated | Upland | California | 91786 | — |
| Clinical Research of West Florida Inc - Clearwater | Clearwater | Florida | 33765-2616 | — |
| Millennium Research | Ormond Beach | Florida | 32174 | — |
| IRIS Research and Development LLC | Plantation | Florida | 33324 | — |
| Clinical Research of West Florida Inc - Tampa | Tampa | Florida | 33606-1246 | — |
| Emory University School of Medicine | Atlanta | Georgia | 30322 | — |
| Bluegrass Community Research Inc | Lexington | Kentucky | 40504-2931 | — |
| NYU Langone Ambulatory Care Brooklyn Heights | Brooklyn | New York | 11201 | — |
| Feinstein Institute For Medical Research | Manhasset | New York | 11030-3816 | — |
| SUNY Upstate Medical Center | Syracuse | New York | 13210 | — |
| DJL Clinical Research | Charlotte | North Carolina | 28210-8509 | — |
| Paramount Medical Research and Consulting LLC | Middleburg Heights | Ohio | 44130-3483 | — |
| Tekton Research Inc | Austin | Texas | 78745-1485 | — |
| Precision Comprehensive Clinical Research Solutions | Colleyville | Texas | 76034-5913 | — |
| Metroplex Clinical Research Center | Dallas | Texas | 75231 | — |
| Southwest Rheumatology Research, LLC | Mesquite | Texas | 75150 | — |
| Spectrum Medical, Inc | Danville | Virginia | 24541-1222 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 50 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04925934, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 22, 2024 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04925934 live on ClinicalTrials.gov.